The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

Share Price Information for Aquis Exchange (AQX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 465.00
Bid: 460.00
Ask: 470.00
Change: 3.00 (0.65%)
Spread: 10.00 (2.174%)
Open: 465.00
High: 465.00
Low: 465.00
Prev. Close: 462.00
AQX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Share Options & Total Voting Rights

15 Apr 2020 07:00

RNS Number : 6387J
Aquis Exchange PLC
15 April 2020
 

 

15 April 2020

Aquis Exchange PLC

("Aquis" or the "Company")

 

Exercise of Share Options

and

Total Voting Rights

 

Aquis Exchange PLC (AIM: AQX), the exchange services group, announces that it has received notification that three former employees have exercised options under the Company's EMI Option Scheme over 20,137 ordinary shares of 10p each in the Company ("Ordinary Shares") at an exercise price of £2.69 per share.

 

Application has been made for 20,137 new Ordinary Shares to be admitted to trading on AIM, which is expected to take place on 20 April 2020. The new Ordinary Shares will rank pari pasu with the existing Ordinary Shares in issue.

 

Total Voting Rights

 

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA, the Company confirms that, following this issue, its issued share capital will comprise 27,169,696 Ordinary Shares. All Ordinary Shares shall have equal voting rights and none of the Ordinary Shares are held in treasury. Accordingly, the figure of 27,169,696 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

 

Aquis Exchange PLC

Tel: +44 (0) 20 3597 6321

Alasdair Haynes, CEO

Jonathan Clelland, CFO and COO

Belinda Keheyan, Head of Marketing

Tel: +44 (0) 7768 078110

Liberum Capital Limited (Nominated Adviser and Broker)

Tel: +44 (0) 20 3100 2000

Clayton Bush

Chris ClarkeEdward Thomas

Kane Collings

Alma PR (Financial PR Adviser)

Tel: +44 (0)20 3405 0209

Caroline Forde

Susie Hudson

Rebecca Sanders-Hewett

aquis@almapr.co.uk

 

About Aquis Exchange

 

Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).

 

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK and in EU27 respectively. Aquis operates a lit order book and does not allow aggressive non-client proprietary trading, which has resulted in lower toxicity and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

 

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is permissioned as a Recognised Investment Exchange, which allows it to operate a regulated listings venue.

 

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

 

Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRQZLFFBZLBBBV
Date   Source Headline
24th Apr 20207:00 amRNSPublication of ARA and Notice of AGM
20th Apr 20207:00 amRNSIssue of Options and Director/PDMR Notification
16th Apr 20207:00 amRNSFinal results
15th Apr 20207:00 amRNSExercise of Share Options & Total Voting Rights
24th Mar 20207:00 amRNSUpdate to Results Announcement Date
4th Mar 20203:49 pmRNSFCA Approval of NEX Exchange Acquisition
19th Dec 20197:00 amRNSTiming of NEX Exchange Acquisition,Trading Update
22nd Nov 20192:40 pmRNSDirector/PDMR Notification
17th Sep 20197:00 amRNSInterim results for six months ended 30 June 2019
28th Aug 20197:00 amRNSNotice of Results
5th Jul 20197:00 amRNSAcquisition of NEX Exchange
27th Jun 20195:57 pmRNSMarket Update
5th Jun 20197:00 amRNSAquis Exchange achieves record market share
30th Apr 20191:16 pmRNSResult of AGM
29th Mar 20197:00 amRNSPublication of Annual Report and Notice of AGM
20th Mar 20191:30 pmRNSConfirmation of Board Appointment
20th Mar 20197:00 amRNSFinal Results for the year ended 31 December 2018
5th Mar 201911:00 amRNSAquis supplies AkinovA with trading technology
26th Feb 20194:38 pmRNSTR-1: Notification of major holdings
19th Feb 20197:00 amRNSTR-1: Notification of major holdings
24th Jan 20197:00 amRNSFrench Regulatory Approval
8th Jan 20197:00 amRNSTrading Update and Board Appointment
7th Jan 20192:14 pmRNSTR-1: Notification of major holdings
4th Dec 201811:13 amRNSAQUIS EXCHANGE RELEASE NOVEMBER TRADING STATISTICS
26th Nov 201811:10 amRNSStandard form for notification of major holdings
21st Nov 201810:17 amRNSDirector/PDMR Notification
16th Oct 20189:54 amRNSTR-1: Notification of major holdings
25th Sep 20187:00 amRNSInterim Results for six months ended 30 June 2018
6th Sep 20187:00 amRNSTechnology Licensing Agreement
4th Sep 20185:19 pmRNSResult of General Meeting
13th Aug 20185:15 pmRNSNotice of General Meeting
4th Jul 20183:59 pmRNSTR-1: Notification of major holdings
14th Jun 20188:30 amRNSDirector/PDMR Shareholding
14th Jun 20187:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.